Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Neoplasms, Squamous Cell 1Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Nivolumab 2pembrolizumab 1osimertinib 1icotinib 1famitinib 1dabrafenib 1cemiplimab 1alirocumab 1aldesleukin 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Radiation 1Pemetrexed 1Panitumumab 1Monatide (IMS 3015) 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Injections 1Immune Checkpoint Inhibitors 1Gefitinib 1Eflornithine 1Drug Therapy 1Cisplatin 1Celecoxib 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Non-Small-Cell Lung × Biological Products × Clear all
NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Cancer Research UK

Phase 1/2 Suspended
15 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡